Sutro Biopharma, Inc.STRONASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank88
3Y CAGR+84.3%
5Y CAGR+107.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+84.3%/yr
vs +8.4%/yr prior
5Y CAGR
+107.4%/yr
Recent deceleration
Acceleration
+75.9pp
Accelerating
Percentile
P88
Within normal range
vs 5Y Ago
38.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$190.30M+174.7%
2023$69.27M+46.6%
2022$47.25M+55.4%
2021$30.41M-85.2%
2020$206.15M+4056.3%
2019$4.96M-96.0%
2018$125.30M+469.0%
2017$22.02M+89.9%
2016$11.59M-